Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3
Chemical Name: 1-[4-(diphenylmethyl)piperazin-1-yl]-3
3-Benzodioxol-5-ylmethyl)-2
AX20017 does not affect the human kinases
Treatment with RG108 results in the demethylation of genomic DNA and can reactivate epigenetically silenced tumor suppressor genes
(−)-Apomorphine (hydrochloride) Catalog No.:M22410-C The lipid-lowering effects of lomitapide() Apomorphine is a non selective dopamine receptor agonist that exhibits pKi values of 6. 43, 7. 08, 7. 59, 8. 36, and 7. 83 for human recombinant D1, D2L, D3, D4, and D5 receptors, respectively., It produces biphasic effects on locomotor activity and displays anti parkinsonian and neuroprotective actions.[1,], . Millan, M. J., Maiofiss, L., Cussac, D., et al. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor.
US$ 33.00
US$ 39.00
US$ 35.00
US$ 28.00